{"id":27879,"date":"2021-03-08T08:11:51","date_gmt":"2021-03-08T06:11:51","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/?p=27879"},"modified":"2023-05-24T13:00:16","modified_gmt":"2023-05-24T13:00:16","slug":"information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide","status":"publish","type":"post","link":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/","title":{"rendered":"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide"},"content":{"rendered":"\n<p><strong>Paris&nbsp;(France), le 8 mars 2021 \u2013&nbsp;<\/strong>Ipsen a appris qu\u2019Amdipharm Ltd, qui serait une filiale d\u2019Advanz Pharma, a re\u00e7u une r\u00e9ponse favorable par le Danemark, \u00c9tat membre de r\u00e9f\u00e9rence pour la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e, pour une formulation g\u00e9n\u00e9rique de lanr\u00e9otide en doses de 60mg, 90mg et 120mg. Ceci repr\u00e9sente un pas vers la premi\u00e8re approbation r\u00e9glementaire nationale d\u2019un g\u00e9n\u00e9rique de lanr\u00e9otide en Europe. Compte tenu des d\u00e9lais n\u00e9cessaires pour obtenir les autorisations de mise sur le march\u00e9 et le remboursement sp\u00e9cifiques \u00e0 chaque pays, cela est coh\u00e9rent avec les pr\u00e9visions d\u2019Ipsen pour 2021 qui supposent le lancement progressif d\u2019un g\u00e9n\u00e9rique de lanr\u00e9otide en Europe d\u2019ici la mi-2021. Par cons\u00e9quent, il n\u2019y a pas de changement dans les objectifs financiers 2021 de la soci\u00e9t\u00e9 ni dans les perspectives financi\u00e8res \u00e0 moyen terme d\u2019Ipsen pour 2024.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Paris&nbsp;(France), le 8 mars 2021 \u2013&nbsp;Ipsen a appris qu\u2019Amdipharm Ltd, qui serait une filiale d\u2019Advanz Pharma, a re\u00e7u une r\u00e9ponse<\/p>\n","protected":false},"author":9,"featured_media":19250,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3542,1215],"tags":[],"class_list":["post-27879","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mediastatement-fr","category-general-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide - Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide - Global\" \/>\n<meta property=\"og:description\" content=\"Paris&nbsp;(France), le 8 mars 2021 \u2013&nbsp;Ipsen a appris qu\u2019Amdipharm Ltd, qui serait une filiale d\u2019Advanz Pharma, a re\u00e7u une r\u00e9ponse\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-08T06:11:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-24T13:00:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wave-eu-west-1.s3.eu-west-1.amazonaws.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"346\" \/>\n\t<meta property=\"og:image:height\" content=\"346\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"konstantinoskampanos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"konstantinoskampanos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/\"},\"author\":{\"name\":\"konstantinoskampanos\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/8f3494a7e3dfce8dfd5c50292aa809e4\"},\"headline\":\"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide\",\"datePublished\":\"2021-03-08T06:11:51+00:00\",\"dateModified\":\"2023-05-24T13:00:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/\"},\"wordCount\":178,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg\",\"articleSection\":[\"D\u00e9clarations m\u00e9dias\",\"G\u00e9n\u00e9ral\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/\",\"name\":\"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide - Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg\",\"datePublished\":\"2021-03-08T06:11:51+00:00\",\"dateModified\":\"2023-05-24T13:00:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg\",\"width\":346,\"height\":346},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/8f3494a7e3dfce8dfd5c50292aa809e4\",\"name\":\"konstantinoskampanos\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g\",\"caption\":\"konstantinoskampanos\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide - Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/","og_locale":"fr_FR","og_type":"article","og_title":"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide - Global","og_description":"Paris&nbsp;(France), le 8 mars 2021 \u2013&nbsp;Ipsen a appris qu\u2019Amdipharm Ltd, qui serait une filiale d\u2019Advanz Pharma, a re\u00e7u une r\u00e9ponse","og_url":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/","og_site_name":"Global","article_published_time":"2021-03-08T06:11:51+00:00","article_modified_time":"2023-05-24T13:00:16+00:00","og_image":[{"width":346,"height":346,"url":"https:\/\/wave-eu-west-1.s3.eu-west-1.amazonaws.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg","type":"image\/jpeg"}],"author":"konstantinoskampanos","twitter_card":"summary_large_image","twitter_creator":"@ipsengroup","twitter_site":"@ipsengroup","twitter_misc":{"\u00c9crit par":"konstantinoskampanos","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/"},"author":{"name":"konstantinoskampanos","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/8f3494a7e3dfce8dfd5c50292aa809e4"},"headline":"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide","datePublished":"2021-03-08T06:11:51+00:00","dateModified":"2023-05-24T13:00:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/"},"wordCount":178,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg","articleSection":["D\u00e9clarations m\u00e9dias","G\u00e9n\u00e9ral"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/","url":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/","name":"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg","datePublished":"2021-03-08T06:11:51+00:00","dateModified":"2023-05-24T13:00:16+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#primaryimage","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2021\/12\/05105825\/202105_Images_346x346pix_3.jpeg","width":346,"height":346},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/general-fr\/information-relative-a-la-procedure-europeenne-decentralisee-de-lanreotide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Information relative \u00e0 la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e de lanr\u00e9otide"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/8f3494a7e3dfce8dfd5c50292aa809e4","name":"konstantinoskampanos","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/461d8aaa3dc000968b96f9df6ebfd0f045990cabf9f91de7f7dc4b9542e2adc8?s=96&d=mm&r=g","caption":"konstantinoskampanos"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/27879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/comments?post=27879"}],"version-history":[{"count":4,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/27879\/revisions"}],"predecessor-version":[{"id":30194,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/27879\/revisions\/30194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/19250"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=27879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=27879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=27879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}